trending Market Intelligence /marketintelligence/en/news-insights/trending/_lGnZaI0v2hUeTml8-_SRw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Eyegate Pharmaceuticals CFO resigns

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Eyegate Pharmaceuticals CFO resigns

Ryan Brenneman is no longer Eyegate Pharmaceuticals Inc.'s CFO and principal financial and accounting officer.

Brenneman resigned from the positions, prompting company President and CEO Stephen From to assume the role of principal financial and accounting officer.